Results Healthcare   |   Results International

CROs and CMOs

We work with CROs and CMOs in organisation asset restructuring and building core divisions through M&A activity.

CROs and CMOs

Clinical/contract research organisations (CROs) in particular are among the strongest growth sectors of the pharmaceutical industry, with many firms across the sector experiencing double- digit annual growth. This growth is driven by the trend for increased outsourcing by pharmaceutical and biotechnology companies looking to shift fixed to variable costs and access specialist capabilities not found in-house, and an overall increase in biopharmaceutical R&D spending. CROs have also become one of the most active sectors for M&A, with larger players consolidating to achieve critical mass, as well as completing bolt-on acquisitions to offer a more comprehensive service offering.

Our team has a strong track-record in successful CRO transactions.

14 Sep 2020

Results Healthcare advises MSD Animal Health on the divestment of its Segré, France facility to TriRx

Results Healthcare is pleased to announce that it was the exclusive corporate finance advisor to MSD Animal Health on the…

09 Jul 2020

Deal activity and valuations in the healthcare sector during COVID-19

There has been a measurable impact on healthcare deal activity and valuations as a result of COVID-19. Major equity indices…

Subscribe to receive our latest sector-specific research on M&A activity and fundraisings:

Insights

Regular Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights     SUBSCRIBE

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office